Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01722877 · ClinicalTrials.gov registry record · NA
JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions
A NA study of Peripheral Vascular Disease and Restenosis, sponsored by Midwest Cardiovascular Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 2
- Study locations
NCT01722877 is a NA study of Peripheral Vascular Disease and Restenosis that has completed, run by Midwest Cardiovascular Research Foundation. The registered enrollment target is 29 participants, below the 281-participant average among 25 other Peripheral Vascular Disease trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01722877, a NA study of Peripheral Vascular Disease and Restenosis, has completed, sponsored by Midwest Cardiovascular Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 2
- Study locations
Study Summary
Several studies have shown that stenting of the femoropopliteal artery in the lower leg leads to improved overall results compared to balloon angioplasty alone. However, scar tissue development can occur within the stent, a process called restenosis. Treatment of these in-stent restenotic lesions has a high procedural success rate but recurrence of scar tissue is frequently seen. Several methods have been proposed to treat in-stent restenosis in the lower leg arteries but mixed results have been noted. In this study we hypothesize that simultaneous tissue excision and aspiration using the JetStream Navitus device (Medrad) can lead to a high rate of acute procedural success with low intraprocedural complications and an acceptable recurrence rate of restenosis at 6-month follow-up.
Conditions Studied
Interventions
- DEVICE JetStream Navitus
Study Locations (2)
Iowa
- Trinity Bettendorf Medical Center - Bettendorf
Texas
- VA Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01722877
The ClinicalTrials.gov registry entry for NCT01722877 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 281-participant average among 25 other Peripheral Vascular Disease trials with a reported enrollment target (90% lower). The listed sponsor is Midwest Cardiovascular Research Foundation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peripheral Vascular Disease appearing as the primary indexed condition, and to 1 intervention - of which JetStream Navitus is the first listed.
NCT01722877 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Iowa, Texas.
Frequently Asked Questions
What is clinical trial NCT01722877 about?
NCT01722877 is a clinical study titled "JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions". Several studies have shown that stenting of the femoropopliteal artery in the lower leg leads to improved overall results compared to balloon angioplasty alone. However, scar tissue development can occur within the stent, a process called restenosis. Treatment of these in-stent restenotic lesions ha...
What is the current status of trial NCT01722877?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2012-10. Estimated completion is 2015-09.
What conditions does trial NCT01722877 study?
This clinical trial studies the following conditions: Peripheral Vascular Disease, Restenosis.
What interventions are being tested in trial NCT01722877?
The interventions under investigation include: JetStream Navitus (DEVICE).
Who is sponsoring clinical trial NCT01722877?
This trial is sponsored by Midwest Cardiovascular Research Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01722877 being conducted?
This trial has 2 study locations across Iowa, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Vascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Far Red Light to Improve Functioning in PAD
RECRUITING · NA
-
Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease
RECRUITING · NA
-
ENhancing Exercise with LIGHT to Improve Functioning in PAD
RECRUITING · NA
-
The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
COMPLETED · NA
-
A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery
COMPLETED · NA
-
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.